Cargando…
AKT-STAT3 Pathway as a Downstream Target of EGFR Signaling to Regulate PD-L1 Expression on NSCLC cells
While cancer development and progression can be controlled by cytotoxic T cells, it is also known that tumor-specific CD8(+)T cells become functionally impaired by acquiring a group of inhibitory receptors known as immune checkpoints. Amongst those, programmed death-1 (PD-1) is one of the most recog...
Autores principales: | Abdelhamed, Sherif, Ogura, Keisuke, Yokoyama, Satoru, Saiki, Ikuo, Hayakawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039378/ https://www.ncbi.nlm.nih.gov/pubmed/27698894 http://dx.doi.org/10.7150/jca.14713 |
Ejemplares similares
-
Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer
por: REFAAT, ALAA, et al.
Publicado: (2013) -
P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non‐small‐cell lung cancer
por: Kato, Shinichiro, et al.
Publicado: (2016) -
Multi-Pathway Cellular Analysis on Crude Natural Drugs/Herbs from Japanese Kampo Formulations
por: Eshima, Shizuka, et al.
Publicado: (2015) -
Mesenchymal-transitioned cancer cells instigate the invasion of epithelial cancer cells through secretion of WNT3 and WNT5B
por: Kato, Shinichiro, et al.
Publicado: (2014) -
RAC1 inhibition as a therapeutic target for gefitinib-resistant non-small-cell lung cancer
por: Kaneto, Naoki, et al.
Publicado: (2014)